News, Money and Drugs for Tuesday, June 23, 2009

June 23, 2009 at 8:16 pm EST | Tags:

News, Money and Drugs for Tuesday, June 23, 2009

  • Does Paul Abel of the Kinetics Medical Fund have the answer for investing in biotech stocks? [CNN Money]

  • Bayer’s Yaz is a bestseller!!! [BNET Pharma]

  • Bad break up? Ask Biomarin (BMRN) and La Jolla Pharmaceutical (LJPC)… [Xconomy]

  • Osiris Therapeutics’ (OSIR) Prochymal flops its COPD study. [Yahoo!Finance]

  • LabCorp buys Monogram for $155 Million… [BioSpace]

  • AMAG on shopping list? [WSJ]

  • It’s the Graveyard for Cell Genesys (CEGE)! [FierceBiotech]

  • Finally, it’s more legal woes for Wyeth. [Boston Herald]

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts

| News, Money and Drugs for Tuesday, June 30, 2009 | News, Money and Drugs for Tuesday, June 16, 2009 – Zicam Warning, Arzerra Setback, Cell Therapeutics’ Debt Offer… | News, Money and Drugs for Tuesday, June 2, 2009 – Icahn Wins, More CTIC | News, Money and Drugs for Monday, June 8, 2009 | News, Money and Drugs for Monday, June 22, 2009 |


Leave a Reply

Would you like to register?